Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients With Haemophilia A

NCT01493778 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01493778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01493778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients With Haemophilia A
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
September 17, 2012
Completion date
December 5, 2018
Enrollment
60 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a